ARHI Re-expression Induces Autophagy in Breast Cancer Cells and Enhances Paclitaxel Effects
Author Information
Author(s): Zou Chun-Fang, Jia Luoqi, Jin Hongyan, Yao Ming, Zhao Naiqing, Huan Jin, Lu Zhen, Bast Robert C Jr, Feng Youji, Yu Yinhua
Primary Institution: Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University
Hypothesis
Does re-expression of ARHI induce autophagy in breast cancer cells and enhance the effects of paclitaxel?
Conclusion
Re-expression of ARHI induces autophagic cell death in breast cancer cells and enhances the inhibitory effects of paclitaxel.
Supporting Evidence
- ARHI re-expression was shown to induce autophagy in breast cancer cells.
- Paclitaxel alone did not induce autophagy but enhanced ARHI-induced autophagy.
- ARHI re-expression promoted apoptosis and G2/M cell cycle arrest in breast cancer cells.
- Combination treatment with ARHI and paclitaxel significantly inhibited tumor growth in xenograft models.
Takeaway
ARHI is a gene that helps fight breast cancer by making cancer cells die and work better with a drug called paclitaxel.
Methodology
ARHI was re-expressed in breast cancer cells using transfection and drug treatments, and the effects were evaluated in cell cultures and xenograft models.
Limitations
The study primarily focused on specific breast cancer cell lines and may not generalize to all breast cancer types.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website